MVP: Advancing Cancer Care
Most applicable medical specialties: Oncology, hematology
The Advancing Cancer Care MVP focuses on the clinical theme of providing fundamental treatment and management of cancer care. The measures assess three critical areas: the patient experience of care, end of life care, and appropriate diagnostics along with possible treatment options for different cancer diagnoses.
Quality
To fulfill quality requirements:
- You must select 4 quality measures from the list below
(exception for clinicians in a small practice – see # 3 below) - At least 1 measure must be an outcome measure
- If no outcome measures are available, you may report a high priority measure.
- If you are part of a small practice (i.e., 15 or fewer clinicians) reporting quality measures through Medicare Part B claims, you don’t need to report additional measures beyond the Medicare Part B claims measures available in this MVP. Reporting all of the Medicare Part B claims measures in this MVP will fulfill your quality reporting requirements.
- You must collect data for each measure for the 12-month performance period of the associated performance year
(e.g., January 1, 2024 – December 31, 2024).
TIP: For small practices (participating at the individual, group or subgroup level) reporting Medicare Part B claims measures: To meet data completeness requirements, you’ll need to start reporting the Medicare Part B claims measures in your selected MVP in January 2024, prior to the MVP registration period.
TIP: Make sure that you select measures that are appropriate to your patient population. Measures that don’t meet
case minimum or data completeness criteria will earn zero points.
Quality Measures (MVP ID: M0001)
| ID | Title | Specs |
|---|---|---|
| 047 | Advance Care Plan | Details |
| 134 | Preventive Care and Screening: Screening for Depression and Follow-Up Plan | Details |
| 143 | Oncology: Medical and Radiation – Pain Intensity Quantified | Details |
| 144 | Oncology: Medical and Radiation – Plan of Care for Pain | Details |
| 321* | CAHPS for MIPS Clinician/Group Survey | Details |
| 450 | Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive Breast Cancer | Details |
| 451 | RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy | Details |
| 452 | Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies | Details |
| 453 | Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better) | Details |
| 457 | Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score – better) | Details |
| 462 | Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy | Details |
| 487 | Screening for Social Drivers of Health | Details |
| 490 | Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated with Immune Checkpoint Inhibitors | Details |
| 503 | Gains in Patient Activation Measure (PAM) Scores at 12 Months | Details |
| PIMSH2* | Oncology: Utilization of GCSF in Metastatic Colorectal Cancer | Not supported by MIPSpro* |
| PIMSH13* | Oncology: Mutation Testing for Stage IV Lung Cancer Completed Prior to the Start of Targeted Therapy | Not supported by MIPSpro* |
Improvement Activities
You must report 1 of the following 3 options:
1. Two medium weighted improvement activities from the list below, or
2. One high weighted improvement activity from the list below, or
3. The IA_PCMH activity (participation in a certified or recognized patient-centered medical home or a comparable specialty practice).
Improvement Activities (MVP ID: M0001)
| ID | Title |
|---|---|
| IA_BE_4 | Engagement of patients through implementation of improvements in patient portal |
| IA_BE_6 | Regularly Assess Patient Experience of Care and Follow Up on Findings |
| IA_BE_15 | Engagement of Patients, Family, and Caregivers in Developing a Plan of Care |
| IA_BE_24 | Financial Navigation Program |
| IA_BMH_12 | Promoting Clinician Well-Being |
| IA_CC_1 | Implementation of Use of Specialist Reports Back to Referring Clinician or Group to Close Referral Loop |
| IA_CC_13 | Practice Improvements to Align with OpenNotes Principles |
| IA_CC_17 | Patient Navigator Program |
| IA_EPA_1 | Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient’s Medical Record |
| IA_EPA_2 | Use of telehealth services that expand practice access |
| IA_ERP_4 | Implementation of a Personal Protective Equipment (PPE) Plan |
| IA_MVP | Practice-Wide Quality Improvement in MIPS Value Pathways |
| IA_PCMH | Electronic Submission of Patient Centered Medical Home accreditation |
| IA_PM_14 | Implementation of methodologies for improvements in longitudinal care management for high risk patients |
| IA_PM_15 | Implementation of episodic care management practice improvements |
| IA_PM_16 | Implementation of medication management practice improvements |
| IA_PM_21 | Advance Care Planning |
| IA_PSPA_16 | Use of decision support and standardized treatment protocols |
| IA_PSPA_28 | Completion of an Accredited Safety or Quality Improvement Program |
Cost
Important information to consider:
- You don’t have to submit any data for this performance category. We’ll use Medicare claims data to
calculate your cost measure performance.
(You don’t select cost measures during MVP registration. CMS will calculate your performance
on all the cost measures included in the MVP based on available Medicare claims data.) - You’ll only be scored on the cost measures in this MVP for which you meet or exceed the established
case minimum.
Cost Measures (MVP ID: M0001)
| ID | Title | Specs |
|---|---|---|
| TPCC_1 | Total Per Capita Cost (TPCC) | Details |
Foundational Layer – Promoting Interoperability
To fulfill Promoting Interoperability requirements:
- Submit the required Promoting Interoperability measures (the same as under traditional MIPS) listed below. Bonus points are available for reporting measures that aren’t required.
- If you’re reporting as a subgroup, you’ll submit your affiliated group’s data for the Promoting Interoperability performance category.
- Review if you qualify for automatic reweighting of the Promoting Interoperability performance category based on your clinician type, special status, or an approved Promoting Interoperability Performance Category Hardship Exception Application.
Clinician Types for Automatic Reweighting:
- Clinical social worker
Special Status for Automatic Reweighting:
- Ambulatory Surgical Center (ASC)-based
- Hospital-based
- Non-patient facing
- Small practice
Promoting Interoperability Performance Category Hardship Exception Qualifications:
- Decertified EHR technology
- Insufficient internet connectivity
- Experience extreme and uncontrollable circumstances (e.g., disaster, practice closure, severe financial distress, vendor issues)
- Lack control over availability of CEHRT (Certified Electronic Health Record Technology)
Note: Promoting Interoperability requirements are the same in MVPs as they are in traditional MIPS. Learn more about Promoting Interoperability requirements.
Promoting Interoperability Measures (All MVPs)
| ID | Title |
|---|---|
| PI_EP_1 | e-prescribing |
| PI_EP_2 | Query of the Prescription Drug Monitoring Program (PDMP) |
| PI_EP_2_EX_1 | Query of the Prescription Drug Monitoring Program (PDMP) Exclusion |
| PI_EP_2_EX_2 | Query of the Prescription Drug Monitoring Program (PDMP) Exclusion |
| PI_HEI_1 | Support Electronic Referral Loops By Sending Health Information |
| PI_HEI_4 | Support Electronic Referral Loops By Receiving and Reconciling Health Information |
| PI_HEI_5 | Health Information Exchange (HIE) Bi-Directional Exchange |
| PI_HEI_6 | Enabling Exchange Under TEFCA |
| PI_LVITC_2 | Support Electronic Referral Loops By Receiving and Reconciling Health Information Exclusion |
| PI_LVOTC_1 | Support Electronic Referral Loops By Sending Health Information Exclusion |
| PI_LVPP_1 | e-Prescribing Exclusion |
| PI_ONCACB_1 | ONC-ACB Surveillance Attestation |
| PI_ONCDIR_1 | ONC Direct Review Attestation |
| PI_PEA_1 | Provide Patients Electronic Access to Their Health Information |
| PI_PHCDRR_1 | Immunization Registry Reporting |
| PI_PHCDRR_2 | Syndromic Surveillance Reporting |
| PI_PHCDRR_3 | Electronic Case Reporting |
| PI_PHCDRR_4 | Public Health Registry Reporting |
| PI_PHCDRR_5 | Clinical Data Registry Reporting |
| PI_PPHI_1 | Security Risk Analysis |
| PI_PPHI_2 | High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides |
| PI_INFBLO_1 | Actions to Limit or Restrict the Compatibility of CEHRT |
Foundational Layer – Population Health
You must select 1 population health measure at the time of MVP registration.
- You don’t have to submit any data for this measure, CMS will calculate the population health measures for you using administrative claims data.
- This measure will be excluded from scoring if the measure doesn’t have a benchmark or meet the case minimum.
- Population health isn’t a new performance category. The population health measure you select during MVP registration will be scored as part of the quality performance category provided you meet the case minimum.
- Subgroups will be evaluated at the affiliated group level.
Improvement Activities (All MVPs)